life sciences
UK at a Crossroads: Fix Systemic R&D or Forfeit Economic Superpower Status?
A stark report warns the UK’s systemic R&D weakness threatens its economy. Without decisive action, major projects and investments are at risk.
Thermo Fisher’s $10 Billion Bet: Unpacking the Mega-Deal for Clario and the Future of Drug Development
Thermo Fisher’s potential $10B acquisition of Clario signals a major shift in the drug development landscape, blending healthcare, data, and finance.